Catalyst Wire Dossier Catalyst Wire Dossier

SVT-40776

SVT-40776 · Salvat
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SVT-40776, covering 2011-06-08 to 2011-06-08. Get the full timeline:

Most recent: Clinical Trial Update: SVT-40776 in Patients Suffering From Overactive Bladder Syndrome [Phase 2]

See pricing